Hunter C. Smith
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Hunter C. Smith
Earlier roles on record: Board Member at Spyre Therapeutics, Inc. (SYRE) until November 22, 2023. Spyre Therapeutics, Inc. reported in an 8-K filed November 28, 2023 that Hunter C. Smith resigned as Board, effective November 22, 2023.
“Effective as of November 22, 2023, Ivana Magovčević-Liebisch, Ph.D., J.D. and Hunter C. Smith, M.B.A. resigned from the Board.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
2021-01-01–2023-11-22
Company network
Recorded roles and call appearances connecting this person to public companies.
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.